Align Technology, Inc.(ALGN) Stock Research - Grey Stern Research
Loading...

Align Technology, Inc. (ALGN) Stock Analysis

$171.41 (2.53%)

ALGN Financial Performance


Use the table below to view Align Technology, Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q3 - 2024

Metric Value Ranking among Peers
Price $171.41 -
52 Week Low $141.74 -
52 Week High $327.49 -
Market Cap $12.5 Billion 9/15
Gross Margin 70% 7/15
Profit Margin 10% 11/15
EBITDA margin 14% 11/15
Q3 - 2024 Revenue $995.2 Million 7/15
Q3 - 2024 Earnings $103.8 Million 7/15
Q3 - 2024 Free Cash Flow $0 Million 13/15
Trailing 4 Quarters Revenue $4.0 Billion 7/15
Trailing 4 Quarters Earnings $421.4 Million 7/15
Quarterly Earnings Growth -16% 11/15
Annual Earnings Growth -14% 12/15
Quarterly Revenue Growth 4% 12/15
Annual Revenue Growth 4% 10/15
Cash On Hand $1.0 Billion 5/15
Short Term Debt $0 14/15
Long Term Debt $88.2 Million 10/15

Align Technology, Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Align Technology, Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 29.78 9/15
PS 3.14 13/15
PB 3.26 12/15
PC 12.02 13/15
Liabilities to Equity 0.61 9/15
ROA 0.07 7/15
ROE 0.11 8/15
Current Ratio 2.63 6/15
Quick Ratio 0.44 10/15
Long Term Debt to Equity 0.02 12/15
Debt to Equity 0.02 14/15
Burn Rate -10.41 12/15
Cash to Cap 0.08 3/15
CCR 13/15
EV to EBITDA 80.43 10/15
EV to Revenue 2.90 13/15

Company Details

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

CEO: Mr. Joseph Hogan

Website: https://www.aligntech.com

Address: 2820 Orchard Pkwy San Jose, CALIFORNIA

Exchange: NASDAQ Global Select

Industry: Medical Devices

Align Technology, Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Align Technology, Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Boston Scientific Corporation BSX $140.7 Billion
Abbott Laboratories ABT $227.2 Billion
Medtronic plc MDT $105.9 Billion
Tandem Diabetes Care, Inc. TNDM $1.1 Billion
DexCom, Inc. DXCM $26.9 Billion
Edwards Lifesciences Corporation EW $42.1 Billion
Stryker Corporation SYK $132.3 Billion
Insulet Corporation PODD $17.3 Billion
Penumbra, Inc. PEN $10.7 Billion
Inspire Medical Systems, Inc. INSP $4.5 Billion
InMode Ltd. INMD $1.0 Billion
ShockWave Medical, Inc. SWAV $12.6 Billion
TransMedics Group, Inc. TMDX $3.0 Billion
Inari Medical, Inc. NARI $4.7 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
ALGN Income Statements
Quarter Year Revenue Earnings
Q4 2024 $ 995.2 Million $103.8 Million
Q3 2024 $ 977.9 Million $116.0 Million
Q2 2024 $ 1.0 Billion $96.6 Million
Q1 2024 $ 997.4 Million $105.0 Million
Q4 2023 $ 956.7 Million $124.0 Million
Q3 2023 $ 960.2 Million $121.4 Million
Q2 2023 $ 1.0 Billion $111.8 Million
Q1 2023 $ 943.1 Million $87.8 Million

View All

ALGN Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q4 2024 $1.0 Billion $6.2 Billion $88.2 Million $3.9 Billion
Q3 2024 $1.0 Billion $6.4 Billion $96.4 Million $3.9 Billion
Q2 2024 $761.4 Million $6.2 Billion $129.1 Million $3.8 Billion
Q1 2024 $865.8 Million $6.2 Billion $126.4 Million $3.8 Billion
Q4 2023 $937.4 Million $6.1 Billion $97.0 Million $3.6 Billion
Q3 2023 $1.2 Billion $6.3 Billion $98.5 Million $3.8 Billion
Q2 2023 $952.0 Million $6.1 Billion $104.7 Million $3.6 Billion
Q1 2023 $832.4 Million $5.9 Billion $99.0 Million $3.5 Billion

View All

ALGN Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2024 $326.5 Million $62.8 Million $281.6 Million
Q2 2024 $106.4 Million -$53.5 Million -$104.4 Million
Q1 2024 $19.3 Million -$9.4 Million -$71.6 Million
Q4 2023 $13.5 Million -$33.4 Million -$300.8 Million
Q3 2023 $287.2 Million $0 $287.1 Million
Q2 2023 $251.8 Million $0 $119.6 Million
Q1 2023 $135.8 Million -$64.1 Million -$109.7 Million
Q4 2022 $91.5 Million -$53.2 Million -$102.4 Million

View All